HGF and cancer: This platform, which is similar to the phosphorylation assays described above except whole cell lysates are substituted for the purified kinase, revealed changes in the phosphorylation profiles of immortalized U373 cancer cells and gliablastoma tumors upon hepatocyte growth factor (HGF)-mediated activation of the c-Met signaling pathway.